About this trial
This study was designed to determine the effect of functional mobility levels of stroke patients on caregiver burden, anxiety, and depression in their caregivers.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Diagnosed with stroke according to WHO criteria (≥20% disability rate documented in Adult Disability Health Board Report)
Having a family member or relative who provides care
First-ever and unilateral stroke
Willing to participate voluntarily
Disqualifiers
Presence of severe comorbid conditions
Unwillingness to participate
History of multiple strokes
Bilateral hemiplegia
Trial population
This study includes adult individuals with a first-ever unilateral stroke and their primary caregivers. Stroke patients aged 18-75 years, at least 3 months post-stroke, with sufficient cognitive function (MMSE ≥24), and stable medical status are included. Caregivers are adults who have been living with the patient for at least one year and are the primary, non-professional caregivers.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Brunnstrom Stages of Hemiplegic Recovery
Beck Depression Inventory
The Beck Depression Inventory (BDI) is scored between 0 and 63, where 0 indicates minimal or no depressive symptoms and 63 reflects severe depression; increasing scores correspond to greater severity of depressive symptomatology.
Beck Anxiety Inventory
Beck Anxiety Inventory (BAI) ranges from 0 to 63, with 0 indicating minimal anxiety and 63 indicating severe anxiety; higher scores represent increased severity of anxiety symptoms.
Burden Interview
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: